Parascript launches AccuDetect 4.0 for mammography screening
23 Nov 2010
Parascript has released AccuDetect 4.0, the next generation of
its computer-aided detection (CAD) software for breast cancer screening.
It has significant performance improvements and a greater potential
for lowering false-positive rates when detecting suspicious lesions
on mammograms, compared to the previous version of the product.
AccuDetect 4.0 is unique in that it achieves high sensitivity and
low false positive rates through the integration of several
complimentary algorithms and a sophisticated voting scheme within a
single CAD system.
Available for OEM customers interested in reducing false-positive
rates of existing CAD systems, it is intended to assist radiologists
in the early detection of breast cancer during mammography screening
AccuDetect is tuned to work with the leading full field digital
and computed radiography vendors. The software recently received CE
Mark approval and is deployed in the European Union.
"At Parascript, we are continually working towards improving the
performance levels of our computer-aided detection algorithms to
reach results comparable to the trained radiologist's eye," said
Yuri Prizemin, director of product marketing for Parascript. "We are
very excited to have made such significant strides as we have this
year with AccuDetect."
CAD systems are typically relied upon to identify and highlight
hard-to-find features and anomalies on medical images that may be
indicative of cancer and bring them to the attention of
radiologists. AccuDetect automatically identifies and clearly marks
suspicious areas without obscuring the region of interest, enabling
a more accurate interpretation of mammograms and increased detection
of calcifications and masses.